Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
Completed · Phase 2
Conditions studied: Brain and Central Nervous System Tumors
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of methotrexate, mechlorethamine, vincristine, procarbazine, and prednisone in treating children with astrocytomas or primitive neuroectodermal tumors.
Key facts
- Study ID
- NCT00002463
- Run by
- M.D. Anderson Cancer Center
- People needed
- 4
- Starts
- 1989-02-01
- Expected to finish
- 2008-01-01
- Last updated by the study team
- 2013-02-18
Who can join
Age: any, up to 3. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Texas - MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.